ACIU: AC Immune SA Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 258.23
Enterprise Value ($M) n/a
Book Value ($M) 130.16
Book Value / Share 1.32
Price / Book n/a
NCAV ($M) 73.51
NCAV / Share 0.74
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) -0.30
Return on Assets (ROA) -0.22
Return on Equity (ROE) -0.25

Liquidity (mrq)
Quick Ratio 1.86
Current Ratio 1.86

Balance Sheet (mrq) ($M)
Current Assets 187.59
Assets 244.25
Liabilities 114.08
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
12-13 13G/A AFFiRiS AG 6.50 -2.28
11-14 13G/A Biotechnology Value Fund L P 19.70 33.98

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-14 27,961 173,015 16.16
2025-01-13 19,700 175,064 11.25
2025-01-10 12,353 69,068 17.89

(click for more detail)

Similar Companies
ACET – Adicet Bio, Inc. ACRV – Acrivon Therapeutics, Inc.
ADMA – ADMA Biologics, Inc.


Financial data and stock pages provided by
Fintel.io